Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every funding round, exec hire, M&A move, contract, and sentiment shift on ArrePath — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

ArrePath, Inc. secured £1 million in a grant from PACE to advance the development of novel antibiotics targeting multidrug-resistant infections.

PRIVATENov 19, 2024•over 1 year ago

Amount Raised

£1 Million

Round Type

seed

PrincetonInformation TechnologySoftwareData And AnalyticsScience And Engineering

Description

ArrePath, Inc. has been awarded a £1 million non-dilutive grant from PACE to support its efforts in developing a new class of antibiotics against multidrug-resistant bacterial infections. The funding will help advance their lead program towards IND-enabling studies for complicated urinary tract infections caused by MDR organisms.

Company Information

Company

ArrePath

Location

Princeton, New Jersey, United States

About

ArrePath is a biotech company discovering and developing new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies. We apply world-class science and innovation in imaging and AI / ML technologies to identify and develop novel drugs to address global health issues. Our advanced machine learning (ML) and imaging-based drug discovery platform enables a rapid and efficient identification of new drug classes with desired activity profiles and clinical utility, coupled with a deep understanding of mechanism of action at the outset of the discovery process.

Predictive Intelligence
Strategic

ML-powered predictions for ArrePath's next move

Learn about Strategic plan

Related People

Suggested for you
1 contact

Sign in to view contact details

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, FundzIQ™ for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching ArrePath? See every signal — funding, hires, M&A, contracts, sentiment.

See plans